2Morrow

2Morrow, Inc. was founded in 2012 and is a pioneer in providing science-based digital health solutions. Committed to developing evidence-based medical programs, the initiative combines technology and behavioral science to address some of today's biggest healthcare challenges, including smoking, weight management, stress/anxiety, and chronic pain. This innovative approach stems from collaboration with researchers at Seattle's Fred Hutchinson Cancer Research Center and incorporates Acceptance and Commitment Therapy (ACT). 2Morrow currently partners with employers, retailers, states, health plans, providers, and public health organizations to deliver programs directly to those who need them most through the convenience and privacy of smartphones. 2Morrow is dedicated to delivering science-based digital health solutions and has been recognized as one of the top 15 startups in patient engagement by MedCity News in 2016, ranked second as the best company at the Cascadia Venture Forum in 2016, and achieved the highest honor for its smoking cessation program at the Employee Health & Benefits Conference.